Nevro Corp.

NYSE NVRO

Nevro Corp. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -19.83%

Nevro Corp. Operating Income Margin is -19.83% for the Trailing 12 Months (TTM) ending September 30, 2024, a 21.53% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Nevro Corp. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -25.28%, a 5.47% change year over year.
  • Nevro Corp. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -26.74%, a -23.04% change year over year.
  • Nevro Corp. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -21.73%, a -8.18% change year over year.
  • Nevro Corp. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -20.09%, a 17.45% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
NYSE: NVRO

Nevro Corp.

CEO Mr. Kevin R. Thornal
IPO Date Nov. 6, 2014
Location United States
Headquarters 1800 Bridge Parkway
Employees 1,215
Sector Healthcare
Industries
Description

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Similar companies

FNA

Paragon 28, Inc.

USD 13.01

-0.08%

OFIX

Orthofix Medical Inc.

USD 18.20

-0.71%

GKOS

Glaukos Corporation

USD 156.08

-0.23%

NPCE

NeuroPace, Inc.

USD 13.61

-1.09%

SGHT

Sight Sciences, Inc.

USD 2.73

-2.50%

SRDX

Surmodics, Inc.

USD 34.07

0.09%

CVRX

CVRx, Inc.

USD 15.46

-3.25%

CNMD

CONMED Corporation

USD 71.21

-0.79%

LIVN

LivaNova PLC

USD 49.95

-1.36%

IRMD

IRadimed Corporation

USD 59.35

0.24%

ELMD

Electromed, Inc.

USD 33.88

-1.51%

ITGR

Integer Holdings Corporation

USD 138.24

-2.80%

KIDS

OrthoPediatrics Corp.

USD 24.05

0.21%

RXST

RxSight, Inc.

USD 33.70

-0.50%

LUNG

Pulmonx Corporation

USD 5.84

2.82%

StockViz Staff

February 4, 2025

Any question? Send us an email